| This article has been cited by |
| 1 | Medicinal Cannabis and Central Nervous System Disorders | |
| Yuma T. Ortiz,Lance R. McMahon,Jenny L. Wilkerson |
| Frontiers in Pharmacology.2022;13() |
| [DOI] |
|
| 2 | The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis | |
| Jiantao Zhao,Xuemei Wang,Zijun Huo,Yanchun Chen,Jinmeng Liu,Zhenhan Zhao,Fandi Meng,Qi Su,Weiwei Bao,Lingyun Zhang,Shuang Wen,Xin Wang,Huancai Liu,Shuanhu Zhou |
| Cells.2022;11(13)2049 |
| [DOI] |
|
| 3 | Screening of Natural Compounds Against SOD1 as a Therapeutic Target
for Amyotrophic Lateral Sclerosis | |
| Sonu Pahal,Amit Chaudhary,Sangeeta Singh |
| Letters in Drug Design & Discovery.2022;19(10)877 |
| [DOI] |
|
| 4 | Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration | |
| Ayaz M. Belkozhayev,Minnatallah Al-Yozbaki,Alex George,Raigul Ye Niyazova,Kamalidin O. Sharipov,Lee J. Byrne,Cornelia M. Wilson |
| Current Neuropharmacology.2022;20(8)1450 |
| [DOI] |
|
| 5 | Dioxinodehydroeckol: A Potential Neuroprotective Marine Compound Identified by In Silico Screening for the Treatment and Management of Multiple Brain Disorders | |
| Faizan Ahmad,Punya Sachdeva,Bhuvi Sachdeva,Gagandeep Singh,Hemant Soni,Smriti Tandon,Misbahuddin M. Rafeeq,Mohammad Zubair Alam,Hanadi M. Baeissa,Mohammad Khalid |
| Molecular Biotechnology.2022;20(8)1450 |
| [DOI] |
|
| 6 | Retinal abnormalities in transgenic mice overexpressing aberrant human FUS[1-359] gene | |
| VO Soldatov,MS Kukharsky,MO Soldatova,OA Puchenkova,YuA Nikitina,EA Lysikova,NL Kartashkina,AV Deykin,MV Pokrovskiy |
| Bulletin of Russian State Medical University.2021;20(2021(4))1450 |
| [DOI] |
|
| 7 | Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations | |
| Hee Ra Park,Eun Jin Yang |
| Diagnostics.2021;11(9)1546 |
| [DOI] |
|
